Technology | March 22, 2010

FFR Access Expanded With Hemodynamic System Integrations

March 22, 2010 – Fractional flow reserve (FFR) technology from Volcano Corp. now integrates with the FFR modules of hemodynamic monitoring systems from GE, Siemens, McKesson, and Mennen.

The use of the company’s FFR functional flow measurement tool has grown 79 percent in the last year, driven primarily by the landmark FAME study data and new guidelines encouraging use of FFR by the American College of Cardiology. The FAME study demonstrated a 34 percent reduction in death and myocardial infarction (MI), and a more than $2,000 reduction in costs for patients guided by FFR instead of angiography alone.

Volcano's Smart Map Pressure Instrument and PrimeWire Pressure Guide Wire are now compatible with the majority of hemodynamic monitoring systems, making the benefits of FFR accessible to more clinicians and patients. Volcano's SmartMap will provide a pressure reading to GE Healthcare's Mac-Lab XT and XTi hemodynamic recording systems version 6.8.1, Siemens' AXIOM Sensis XP VC11, McKesson's Horizon Cardiology Hemo version 12.1, and Mennen's Horizon XVu Hemodynamic Monitoring System. With the pressure measurement derived from Volcano's PrimeWire, hemodynamic monitoring systems have the ability to calculate the FFR gradient and display the FFR measurement on the hemodynamic screen in the cath lab.

For more information: www.volcanocorp.com

Related Content

BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | FFR Technologies | December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Videos | FFR Technologies | November 15, 2017
A discussion with William Fearon, M.D.
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | FFR Technologies | November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies | November 08, 2017
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017...
FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone. TCT 2017

FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone.

News | FFR Technologies | November 06, 2017
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a p
Acist Medical Systems Announces Approval and Launch of Next-Generation FFR System
Technology | FFR Technologies | November 03, 2017
Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini System, the next-...
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies | August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Technologies | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Technologies | July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
News | FFR Technologies | May 31, 2017
Acist Medical Systems Inc. announced results from the ACIST-FFR Study demonstrating the consistent and correlative...
Overlay Init